GALENA GENETICS, LLC – Trademark Portfolio

Entity Type: 16

GALENA GENETICS, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 5 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BETTER-LIFE. The owner is based in TRIMONT, MN.

211 MAIN STREET

P.O. BOX B

TRIMONT, MN 56176

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GALENA GENETICS, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

31
Natural Agricultural Products (5 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does GALENA GENETICS, LLC have?

GALENA GENETICS, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.

What trademark classes does GALENA GENETICS, LLC file in?

GALENA GENETICS, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 36 (Insurance & Financial). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.

What are GALENA GENETICS, LLC's most well-known trademarks?

GALENA GENETICS, LLC's registered trademark portfolio includes well-known marks such as BETTER-LIFE. These are among 1 currently registered trademark in the portfolio.

What is GALENA GENETICS, LLC's trademark registration success rate?

GALENA GENETICS, LLC has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.